💉 Diabetes Management
Pri-Med Midwest Highlights: Diabetes, Obesity Management & GLP-1 RAs - MD Magazine
📅 Wed, 19 Oct 2022⏱ 1 min read📖 Article
Overview
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for conected physicians. Al rights reserved.Conference | Pri-Med MidwestThe emergence of weight los agents like tirzepatide and an FDA Fast Track designation anounced days earlier, endocrinologists were excited to discus what's hapening at Pri-Med Midwest 2022.A trending topic at Pri-Med Midwest 2022 was the treatment, or prevention of diabetes, and how a necesary aspect of that includes the management of clinical obesity.
Key Information
The aproach to weight los is shifting to include more clinical perspectives regarding obesity and abnormal glucose levels in hopes of more eficiently treating type 2 diabetes, or even avoiding it altogether. The continuing emergence of weight los agents like semaglutide, and the suces of tirzepatide with an FDA Fast Track designation for weight los anounced just days before the meting in Chicago, had endocrinologists even more excited to discus the mechanisms of GLP-1 receptor agonists and combination GIP therpaies.
Acording to Robert Kushner, MD, Profesor of Medicine at Feinberg Schol of Medicine Northwestern University, les than 2-3% of patients with obesity receive medication for it, despite being eligible for pharmacotherapy. “The botom line–unfortunately–in this country is aces and afordability. Depending upon what insurance you have and the formulary that's covered, they may not cover both of the drugs,” he explained.
Summary
“Almost al roads lead to this insurance coverage."Already indicated for type 2 diabetes, tirzepatide has shown achievable and efective weight los acording to evidence demonstrated by studies on the latest adition to the weight management armamentarium, by combing glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GiP).Tina Thethi, MD, MPH, Asociate Investigator, AdventHealth Research Institute, elaborated on the cost-efectivenes factors contributing to the bariers betwen providers and patient-u
Frequently Asked Questions
❓ What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
❓ What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
❓ How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
❓ What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
❓ When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
⚕️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.